- Home
- LOB vs TARS Comparison
LOB vs TARS Comparison
Compare LOB & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOB
- TARS
- Stock Information
- Founded
- LOB 2008
- TARS 2016
- Country
- LOB United States
- TARS United States
- Employees
- LOB N/A
- TARS N/A
- Industry
- LOB Major Banks
- TARS Medicinal Chemicals and Botanical Products
- Sector
- LOB Finance
- TARS Health Care
- Exchange
- LOB Nasdaq
- TARS Nasdaq
- Market Cap
- LOB 1.5B
- TARS 1.7B
- IPO Year
- LOB 2015
- TARS 2020
- Fundamental
- Price
- LOB $31.55
- TARS $39.53
- Analyst Decision
- LOB Buy
- TARS Strong Buy
- Analyst Count
- LOB 3
- TARS 7
- Target Price
- LOB $42.33
- TARS $67.14
- AVG Volume (30 Days)
- LOB 258.2K
- TARS 522.7K
- Earning Date
- LOB 07-23-2025
- TARS 08-11-2025
- Dividend Yield
- LOB 0.38%
- TARS N/A
- EPS Growth
- LOB N/A
- TARS N/A
- EPS
- LOB 1.21
- TARS N/A
- Revenue
- LOB $406,003,000.00
- TARS $233,674,000.00
- Revenue This Year
- LOB $41.81
- TARS $122.94
- Revenue Next Year
- LOB $10.77
- TARS $44.14
- P/E Ratio
- LOB $26.38
- TARS N/A
- Revenue Growth
- LOB N/A
- TARS 449.03
- 52 Week Low
- LOB $22.68
- TARS $20.08
- 52 Week High
- LOB $50.57
- TARS $57.28
- Technical
- Relative Strength Index (RSI)
- LOB 52.55
- TARS 42.32
- Support Level
- LOB $31.97
- TARS $39.41
- Resistance Level
- LOB $34.42
- TARS $43.33
- Average True Range (ATR)
- LOB 1.08
- TARS 1.56
- MACD
- LOB -0.13
- TARS -0.13
- Stochastic Oscillator
- LOB 34.79
- TARS 7.58
About LOB Live Oak Bancshares Inc.
Live Oak Bancshares Inc operates as the bank holding company for the Live Oak Banking Company. The company specializes in lending and deposit-related services to small businesses nationwide. The company identifies and extends lending to credit-worthy borrowers both within specific industries, also called verticals, through expertise within those industries, and more broadly to select borrowers outside of those industries. A portion of the loans originated by the Bank are partially guaranteed by the Small Business Administration under the 7(a) Loan Program and the U.S. Department of Agriculture Rural Energy for America Program, Water and Environmental Program, Business and Industry and Community Facilities loan programs.
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.